Literature DB >> 32035850

Fifth generation troponin T assay is subject to antibody interference.

Jeffrey Hedley1, Venu Menon1, Leslie Cho1, Adam J McShane2.   

Abstract

BACKGROUND: The fifth generation (high-sensitivity) troponin T assay offers increased precision and analytical sensitivity to the predecessor method. The assay has proven utility in risk stratification and patient management. Upon clinical suspicion and discordant 4th generation troponin T and troponin I results, we investigated a sample for suspected interfering substances to the 5th generation troponin T assay.
METHODS: The analysis included a serial dilution, treatment with polyethylene glycol, commercial antibody blocking reagents, and size exclusion chromatography.
RESULTS: The sample diluted linearly (R2 = 0.9957); however, experienced a dramatic reduction in concentration after both the polyethylene glycol and blocking agent treatment. Finally, size exclusion chromatography demonstrated assay reactivity around 970 kDa range.
CONCLUSIONS: These experiments elucidate a heterophilic antibody interference to the assay, and demonstrate potential measures to discern the interference.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fifth generation troponin T; Heterophilic antibody interference; High-sensitivity troponin T; Troponin T

Year:  2020        PMID: 32035850     DOI: 10.1016/j.cca.2020.02.006

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?

Authors:  Derralynn A Hughes; Patrício Aguiar; Olivier Lidove; Kathleen Nicholls; Albina Nowak; Mark Thomas; Roser Torra; Bojan Vujkovac; Michael L West; Sandro Feriozzi
Journal:  Orphanet J Rare Dis       Date:  2022-02-08       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.